COVID-19 Vaccines: Current and Future Trends
The COVID-19 outbreak has prompted scientists from around the world to design numerous anti-SARS-CoV-2 vaccines based on different technologies and variants.
Educational Objectives
Educational Aim:
The aim of this article is to provide information on the landscape of the pandemic and vaccines to control the SARS-CoV-2 virus spreading.
Editor's comments:
Vaccines are an important part of stopping the spread of COVID-19 in South Africa through the vaccination rollout program. This is because they offer protection to the population, by reducing the risk of infection or the severity of symptoms, also referred to as *herd immunity*. The vaccine is being rolled out in a three-phase approach, that begins with the most vulnerable in our population.
Phase 1: The country’s estimated 1.2 million frontline healthcare workers.
Phase 2: Essential workers, persons in congregate settings, persons over 60-years and persons over 18-years with co-morbidities.
Phase 3: The final phase will target 22,5 million members of the population over the age of 18-years. The target is to vaccinate 67% of the population by the end of 2021, in order to achieve herd immunity.
Educational Outcomes:
Upon completion of this module practitioners should have a clear understanding of:
- anti-SARS-CoV-2 vaccines based on different technologies as well as on-going vaccine development and access of these to differing populations.
Instructions for this Module
- Read the supplied reading material and complete the quiz that follows;
- You have three attempts to pass the quiz;
- The pass grade is 70%;
- You need to pass the quiz to claim your CPD certificate;
- Please click on the CPD certificate link below to claim your CPD certificate and to update your CPD Manager.
If you need any assistance to complete this module, please Contact us